Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,991 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle.
Nakamura J, Aoyagi S, Nanchi I, Nakatsuka S, Hirata E, Shibata S, Fukuda M, Yamamoto Y, Fukuda I, Tatsumi N, Ueda T, Fujiki F, Nomura M, Nishida S, Shirakata T, Hosen N, Tsuboi A, Oka Y, Nezu R, Mori M, Doki Y, Aozasa K, Sugiyama H, Oji Y. Nakamura J, et al. Among authors: yamamoto y. Int J Oncol. 2009 May;34(5):1181-9. Int J Oncol. 2009. PMID: 19360331
The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers.
Oji Y, Tatsumi N, Fukuda M, Nakatsuka S, Aoyagi S, Hirata E, Nanchi I, Fujiki F, Nakajima H, Yamamoto Y, Shibata S, Nakamura M, Hasegawa K, Takagi S, Fukuda I, Hoshikawa T, Murakami Y, Mori M, Inoue M, Naka T, Tomonaga T, Shimizu Y, Nakagawa M, Hasegawa J, Nezu R, Inohara H, Izumoto S, Nonomura N, Yoshimine T, Okumura M, Morii E, Maeda H, Nishida S, Hosen N, Tsuboi A, Oka Y, Sugiyama H. Oji Y, et al. Among authors: yamamoto y. Int J Oncol. 2014 May;44(5):1461-9. doi: 10.3892/ijo.2014.2318. Epub 2014 Mar 4. Int J Oncol. 2014. PMID: 24589652 Free PMC article.
CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma.
Fukusumi T, Ishii H, Konno M, Yasui T, Nakahara S, Takenaka Y, Yamamoto Y, Nishikawa S, Kano Y, Ogawa H, Hasegawa S, Hamabe A, Haraguchi N, Doki Y, Mori M, Inohara H. Fukusumi T, et al. Among authors: yamamoto y. Br J Cancer. 2014 Jul 29;111(3):506-14. doi: 10.1038/bjc.2014.289. Epub 2014 May 29. Br J Cancer. 2014. PMID: 24874475 Free PMC article.
IFN-gamma: a cytokine essential for rejection of CTL-resistant, virus-infected cells.
Yamaguchi S, Tashiro-Yamaji J, Lee K, Takahashi T, Sano K, Endo Y, Nakanishi M, Eguchi A, Okada M, Nomi H, Yamamoto Y, Takenaka H, Kubota T, Yoshida R. Yamaguchi S, et al. Among authors: yamamoto y. J Interferon Cytokine Res. 2005 Jun;25(6):328-37. doi: 10.1089/jir.2005.25.328. J Interferon Cytokine Res. 2005. PMID: 15957956
Enhanced tumor immunity of WT1 peptide vaccination by interferon-β administration.
Nakajima H, Oka Y, Tsuboi A, Tatsumi N, Yamamoto Y, Fujiki F, Li Z, Murao A, Morimoto S, Hosen N, Shirakata T, Nishida S, Kawase I, Isaka Y, Oji Y, Sugiyama H. Nakajima H, et al. Among authors: yamamoto y. Vaccine. 2012 Jan 17;30(4):722-9. doi: 10.1016/j.vaccine.2011.11.074. Epub 2011 Nov 29. Vaccine. 2012. PMID: 22133512
11,991 results
You have reached the last available page of results. Please see the User Guide for more information.